Involvement of the heart by small and medium vessel vasculitis

被引:22
|
作者
Kane, Garvan C. [1 ]
Keogh, Karina A. [2 ]
机构
[1] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA
[2] Mayo Clin, Div Pulm & Crit Care Med, Rochester, MN 55905 USA
关键词
cardiac MRI; Churg-Strauss syndrome; echocardiography; heart; Wegener's granulomatosis; CHURG-STRAUSS-SYNDROME; ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; LEUKOTRIENE RECEPTOR ANTAGONISTS; BRAIN NATRIURETIC PEPTIDE; KAWASAKI-DISEASE; WEGENERS-GRANULOMATOSIS; RHEUMATOID-ARTHRITIS; CARDIAC INVOLVEMENT; ASSOCIATION; RITUXIMAB;
D O I
10.1097/BOR.0b013e32831cb94d
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review The heart may be involved in many different ways by the systemic vasculitides. In this review, we focus on recently described diagnostic and therapeutic issues in small and medium vessel vasculitis of the heart. Recent findings Data have emerged on the prevalence and significance of cardiac involvement in the systemic vasculitides. There is an increasing array of sophisticated imaging modalities including echocardiography, PET, and cardiac MRI that aid in the clinical diagnosis. Summary Most small and medium vessel vasculitides may involve the heart; however, the mode and incidence of cardiac involvement vary with the different vasculitic syndromes. This review describes the various cardiac manifestations of small and medium vessel vasculitis and the advantages of modern imaging modalities including echocardiography, MRI, and PET coupled with biologic biomarkers such as brain natriuretic peptide and antineutrophilic cytoplasmic antibodies in the diagnosis and management of disease.
引用
收藏
页码:29 / 34
页数:6
相关论文
共 50 条
  • [1] Cardiac involvement in small and medium-sized vessel vasculitides
    Pagnoux, C
    Guillevin, L
    LUPUS, 2005, 14 (09) : 718 - 722
  • [2] Medium-size-vessel vasculitis
    Dillon, Michael J.
    Eleftheriou, Despina
    Brogan, Paul A.
    PEDIATRIC NEPHROLOGY, 2010, 25 (09) : 1641 - 1652
  • [3] EULAR recommendations for the management of primary small and medium vessel vasculitis
    Mukhtyar, C.
    Guillevin, L.
    Cid, M. C.
    Dasgupta, B.
    de Groot, K.
    Gross, W.
    Hauser, T.
    Hellmich, B.
    Jayne, D.
    Kallenberg, C. G. M.
    Merkel, P. A.
    Raspe, H.
    Salvarani, C.
    Scott, D. G. I.
    Stegeman, C.
    Watts, R.
    Westman, K.
    Witter, J.
    Yazici, H.
    Luqmani, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (03) : 310 - 317
  • [4] Medium and large vessel vasculitis
    Clivati Brandt, Hebert Roberto
    Arnone, Marcelo
    Sakai Valente, Neusa Yuriko
    Sotto, Mirian Nacagami
    Criado, Paulo Ricardo
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2009, 84 (01) : 55 - 67
  • [5] Pathophysiology of ANCA-associated small vessel vasculitis
    Kallenberg C.G.M.
    Current Rheumatology Reports, 2010, 12 (6) : 399 - 405
  • [6] General characteristics of 29 patients with small vessel vasculitis
    Di Benedetto, Nicolas
    Lopez Mujica, Maria Ximena
    Fernandez, Martin E.
    Touron, Maria
    Munoz, Sebastian A.
    Allievi, Alberto
    MEDICINA-BUENOS AIRES, 2010, 70 (02) : 127 - 132
  • [7] Serological testing in small vessel vasculitis
    Segelmark, Marten
    RHEUMATOLOGY, 2020, 59 : 51 - 54
  • [8] The extent and pattern of organ damage in small vessel vasculitis measured by the Vasculitis Damage Index (VDI)
    Mohammad, A. J.
    Bakoush, O.
    Sturfelt, G.
    Segelmark, M.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2009, 38 (04) : 268 - 275
  • [9] Autoimmune liver disorders and small-vessel vasculitis: four case reports and review of the literature
    Tovoli, Francesco
    Vannini, Antonio
    Fusconi, Marco
    Frisoni, Magda
    Zauli, Danieta
    ANNALS OF HEPATOLOGY, 2014, 13 (01) : 136 - 141
  • [10] Antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis
    Kallenberg, Cees G. M.
    CURRENT OPINION IN RHEUMATOLOGY, 2007, 19 (01) : 17 - 24